Using exome data to identify malignant hyperthermia susceptibility mutations

Stephen G Gonsalves, David Ng, Jennifer J Johnston, Jamie K Teer, Peter D Stenson, David N Cooper, James C Mullikin, Leslie G Biesecker, NISC Comparative Sequencing Program
2013-11-01
Abstract:Background Malignant hyperthermia susceptibility (MHS) is a life-threatening, inherited disorder of muscle calcium metabolism, triggered by anesthetics and depolarizing muscle relaxants. An unselected cohort was screened for MHS mutations using exome sequencing. Our aim was to pilot a strategy for the RYR1 and CACNA1S genes. Methods Exome sequencing was performed on 870 volunteers not ascertained for MHS. Variants in RYR1 and CACNA1S were annotated using an algorithm that filtered results based on mutation type, frequency, and information in mutation databases. Variants were scored on a six-point pathogenicity scale. Medical histories and pedigrees were reviewed for malignant hyperthermia and related disorders. Results We identified 70 RYR1 and 53 CACNA1S variants among 870 exomes. Sixty-three RYR1 and 41 CACNA1S variants passed the quality and frequency metrics but we …
What problem does this paper attempt to address?